Indra Bergval

670 total citations
19 papers, 358 citations indexed

About

Indra Bergval is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Indra Bergval has authored 19 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 13 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Indra Bergval's work include Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (13 papers) and Antibiotic Resistance in Bacteria (4 papers). Indra Bergval is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (13 papers) and Antibiotic Resistance in Bacteria (4 papers). Indra Bergval collaborates with scholars based in Netherlands, United Kingdom and Portugal. Indra Bergval's co-authors include Richard Anthony, Paul R. Klatser, Anja Schuitema, Linda Oskam, Dick van Soolingen, Elis Regina Dalla Costa, Afrânio Lineu Kritski, Taane G. Clark, Raymon Vijzelaar and Claudia E. Coipan and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Indra Bergval

19 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indra Bergval Netherlands 11 290 255 99 90 52 19 358
Miu L. Chin Hong Kong 9 224 0.8× 178 0.7× 153 1.5× 60 0.7× 93 1.8× 10 362
Vanisha Munsamy United States 7 278 1.0× 233 0.9× 118 1.2× 100 1.1× 41 0.8× 8 379
Karine Soetaert Belgium 12 220 0.8× 220 0.9× 109 1.1× 52 0.6× 62 1.2× 17 341
Anja Schuitema Netherlands 11 229 0.8× 227 0.9× 85 0.9× 83 0.9× 30 0.6× 12 392
Ephrem Debebe Zegeye Norway 12 204 0.7× 136 0.5× 168 1.7× 68 0.8× 46 0.9× 20 354
I. G. Shemyakin Russia 12 237 0.8× 215 0.8× 127 1.3× 129 1.4× 32 0.6× 46 405
Sam Ogwang United States 11 288 1.0× 258 1.0× 151 1.5× 84 0.9× 38 0.7× 18 420
Galo A. Goig Switzerland 13 295 1.0× 266 1.0× 140 1.4× 102 1.1× 29 0.6× 25 397
Álvaro Chiner‐Oms Spain 13 262 0.9× 212 0.8× 122 1.2× 75 0.8× 27 0.5× 28 365
Elena V. Kulagina Russia 9 213 0.7× 188 0.7× 140 1.4× 56 0.6× 34 0.7× 19 318

Countries citing papers authored by Indra Bergval

Since Specialization
Citations

This map shows the geographic impact of Indra Bergval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indra Bergval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indra Bergval more than expected).

Fields of papers citing papers by Indra Bergval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indra Bergval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indra Bergval. The network helps show where Indra Bergval may publish in the future.

Co-authorship network of co-authors of Indra Bergval

This figure shows the co-authorship network connecting the top 25 collaborators of Indra Bergval. A scholar is included among the top collaborators of Indra Bergval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indra Bergval. Indra Bergval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zomer, Aldert, et al.. (2024). Host associations of Campylobacter jejuni and Campylobacter coli isolates carrying the L-fucose or d-glucose utilization cluster. International Journal of Food Microbiology. 425. 110855–110855. 2 indexed citations
2.
Coipan, Claudia E., Ingrid Friesema, Angela H. A. M. van Hoek, et al.. (2024). Source attribution of Listeria monocytogenes in the Netherlands. International Journal of Food Microbiology. 427. 110953–110953. 3 indexed citations
3.
Hoek, Angela H. A. M. van, Seung‐Eun Lee, Michel Rapallini, et al.. (2023). Virulence and antimicrobial resistance of Shiga toxin-producing Escherichia coli from dairy goat and sheep farms in The Netherlands. Journal of Applied Microbiology. 134(6). 3 indexed citations
4.
Coipan, Claudia E., Ingrid Friesema, Angela H. A. M. van Hoek, et al.. (2023). New insights into the epidemiology of Listeria monocytogenes – A cross-sectoral retrospective genomic analysis in the Netherlands (2010–2020). Frontiers in Microbiology. 14. 1147137–1147137. 8 indexed citations
5.
6.
Phelan, Jody, Paola Flórez de Sessions, Leopold D. Tientcheu, et al.. (2018). Methylation in Mycobacterium tuberculosis is lineage specific with associated mutations present globally. Scientific Reports. 8(1). 160–160. 31 indexed citations
7.
Bergval, Indra, Anja Schuitema, Jody Phelan, et al.. (2017). Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. BMC Infectious Diseases. 17(1). 491–491. 20 indexed citations
8.
Costa, Elis Regina Dalla, Maria Lúcia Rosa Rossetti, Regina Bones Barcellos, et al.. (2017). Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus. Memórias do Instituto Oswaldo Cruz. 112(6). 396–403. 4 indexed citations
9.
10.
Bablishvili, Nino, Anja Schuitema, Edgar Abadía, et al.. (2014). Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates. BMC Genomics. 15(1). 572–572. 13 indexed citations
11.
Bergval, Indra, Francesc Coll, Anja Schuitema, et al.. (2014). A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture. FEMS Microbiology Letters. 362(2). 1–7. 9 indexed citations
12.
Panaiotov, Stefan, et al.. (2014). Beijing Lineage of MDRMycobacterium tuberculosisin Bulgaria, 2007–2011. Emerging infectious diseases. 20(11). 1899–1901. 4 indexed citations
13.
Bergval, Indra, Brian Kwok, Anja Schuitema, et al.. (2012). Pre-Existing Isoniazid Resistance, but Not the Genotype of Mycobacterium Tuberculosis Drives Rifampicin Resistance Codon Preference in Vitro. PLoS ONE. 7(1). e29108–e29108. 20 indexed citations
14.
Streicher, Elizabeth M., Indra Bergval, Keertan Dheda, et al.. (2012). Mycobacterium tuberculosis Population Structure Determines the Outcome of Genetics-Based Second-Line Drug Resistance Testing. Antimicrobial Agents and Chemotherapy. 56(5). 2420–2427. 44 indexed citations
15.
Beyene, Demissew, Indra Bergval, Elena Hailu, et al.. (2009). Identification and genotyping of the etiological agent of tuberculous lymphadenitis in Ethiopia. The Journal of Infection in Developing Countries. 3(6). 412–419. 26 indexed citations
16.
Bergval, Indra, Anja Schuitema, Paul R. Klatser, & Richard Anthony. (2009). Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance. Journal of Antimicrobial Chemotherapy. 64(3). 515–523. 64 indexed citations
17.
Bergval, Indra, Raymon Vijzelaar, Elis Regina Dalla Costa, et al.. (2007). Development of Multiplex Assay for Rapid Characterization ofMycobacterium tuberculosis. Journal of Clinical Microbiology. 46(2). 689–699. 34 indexed citations
18.
Bergval, Indra, Paul R. Klatser, Anja Schuitema, Linda Oskam, & Richard Anthony. (2007). Specific mutations in theMycobacterium tuberculosis rpoBgene are associated with increaseddnaE2expression. FEMS Microbiology Letters. 275(2). 338–343. 24 indexed citations
19.
Anthony, Richard, Anja Schuitema, Indra Bergval, et al.. (2005). Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency. Annals of Clinical Microbiology and Antimicrobials. 4(1). 9–9. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miu L. Chin Breakdown of academic impact, for papers by Vanisha Munsamy Breakdown of academic impact, for papers by Karine Soetaert Breakdown of academic impact, for papers by Anja Schuitema Breakdown of academic impact, for papers by Ephrem Debebe Zegeye Breakdown of academic impact, for papers by I. G. Shemyakin Breakdown of academic impact, for papers by Sam Ogwang Breakdown of academic impact, for papers by Galo A. Goig Breakdown of academic impact, for papers by Álvaro Chiner‐Oms Breakdown of academic impact, for papers by Elena V. Kulagina
Rankless by CCL
2026